Acutus Medical, Inc. (AFIB)
USD 0.04
(-12.0%)
USD 0.04
(-12.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.16 Million | 16.36 Million | 17.26 Million | 8.46 Million | 2.83 Million | 2.16 Million |
| Cost of Revenue | 10.3 Million | 31.91 Million | 32.92 Million | 15.88 Million | 9.24 Million | 7.51 Million |
| Gross Profit | -3.13 Million | -15.54 Million | -15.66 Million | -7.42 Million | -6.4 Million | -5.34 Million |
| Operating Expenses | 11.22 Million | 75.8 Million | 100.2 Million | 83.81 Million | 64.87 Million | 32.4 Million |
| Selling, General and Administrative Expenses | 7.74 Million | 47.65 Million | 63.52 Million | 50.35 Million | 26.84 Million | 13.33 Million |
| Research and Development Expenses | 3.48 Million | 28.15 Million | 36.68 Million | 33.45 Million | 38.02 Million | 19.07 Million |
| Other Expenses | - | - | - | 97 Thousand | - | - |
| Cost and Expenses | 21.52 Million | 107.71 Million | 133.13 Million | 99.7 Million | 74.11 Million | 39.91 Million |
| Operating Income | -14.36 Million | -27.33 Million | -112.12 Million | -91.33 Million | -72.56 Million | -37.75 Million |
| Interest Expense | 5.65 Million | 5.14 Million | 5.67 Million | 5.5 Million | 22.26 Million | 5.23 Million |
| Income Tax Expense | 63 Thousand | 82 Thousand | 5.67 Million | 23 Thousand | 22.26 Million | -4.92 Million |
| Earnings before Tax | -11.85 Million | -39.53 Million | -117.68 Million | -101.95 Million | -97.03 Million | -47.9 Million |
| Net Income | -81.66 Million | -39.61 Million | -123.36 Million | -101.98 Million | -119.3 Million | -47.9 Million |
| Earnings Per Share Basic | -2.81 | -1.39 | -4.31 | -8.94 | -4.35 | -2.84 |
| Earnings Per Share Diluted | -2.81 | -1.39 | -4.31 | -8.94 | -4.35 | -2.84 |
| Weighted Average Shares Outstanding | 29.09 Million | 28.47 Million | 28.65 Million | 11.4 Million | 27.43 Million | 16.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.09 Million | 28.47 Million | 28.65 Million | 11.4 Million | 27.43 Million | 16.85 Million |
| Gross Margin | -0.44 | -0.95 | -0.91 | -0.88 | -2.26 | -2.47 |
| EBIT Margin | -1.88 | -5.09 | -6.31 | -10.27 | -23.61 | -16.74 |
| Profit Margin | -11.40 | -2.42 | -7.15 | -12.05 | -42.07 | -22.12 |
| EBITDA | -13.48 Million | 35.2 Million | -105.11 Million | -91.33 Million | -68.11 Million | -40.55 Million |
| Earnings Before Tax Margin | -2.00 | -1.67 | -6.49 | -10.79 | -25.59 | -17.43 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.12 Million | 3.62 Million | 7.16 Million | -7.53 Million | 5.23 Million | 5.28 Million |
| Cost of Revenue | 4.47 Million | 3.65 Million | 10.3 Million | -13.14 Million | 8.59 Million | 8.06 Million |
| Gross Profit | -343 Thousand | -30 Thousand | -3.13 Million | 5.61 Million | -3.35 Million | -2.77 Million |
| Operating Expenses | 2.22 Million | 3.33 Million | 11.22 Million | -26.44 Million | 12.22 Million | 16.08 Million |
| Selling, General and Administrative Expenses | 2.22 Million | 3.33 Million | - | -12.21 Million | 7.43 Million | 9.28 Million |
| Research and Development Expenses | - | - | - | -14.23 Million | 4.79 Million | 6.79 Million |
| Other Expenses | 76 Thousand | - | - | - | - | - |
| Cost and Expenses | 6.69 Million | 6.99 Million | 21.52 Million | -39.59 Million | 20.82 Million | 24.14 Million |
| Operating Income | 301 Thousand | -575 Thousand | -14.36 Million | 35.68 Million | -12.93 Million | -17.17 Million |
| Interest Expense | 1.51 Million | 1.47 Million | 5.65 Million | 1.54 Million | 1.4 Million | 1.39 Million |
| Income Tax Expense | 552 Thousand | -10 Thousand | 63 Thousand | -12 Thousand | 75 Thousand | 1.39 Million |
| Earnings before Tax | -362 Thousand | -2.05 Million | -11.85 Million | 35.96 Million | -13.16 Million | -18.34 Million |
| Net Income | -914 Thousand | -1.62 Million | -81.66 Million | -33.76 Million | -13.23 Million | -18.34 Million |
| Earnings Per Share Basic | -0.03 | -0.05 | - | 0.26 | -0.45 | -0.63 |
| Earnings Per Share Diluted | -0.03 | -0.05 | - | 0.26 | -0.45 | -0.63 |
| Weighted Average Shares Outstanding | 29.72 Million | 29.69 Million | 29.09 Million | - | 29.26 Million | 29.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.72 Million | 29.69 Million | 29.09 Million | - | 29.26 Million | 29.03 Million |
| Gross Margin | -0.08 | -0.01 | -0.44 | -0.75 | -0.64 | -0.52 |
| EBIT Margin | -0.49 | -0.78 | - | -4.30 | -2.63 | -3.14 |
| Profit Margin | -0.22 | -0.45 | -11.40 | 4.48 | -2.53 | -3.47 |
| EBITDA | -2.02 Million | -2.82 Million | - | 32.42 Million | -13.78 Million | -16.63 Million |
| Earnings Before Tax Margin | 0.07 | -0.16 | -2.00 | -4.74 | -2.47 | -3.25 |
BSXGF
BAYP
1439
EDSFF
STLAM
LIFE